Keep reading to learn more about lipotropic injections, including the ingredients, cost, dosage, and possible risks
FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
This matters because many adults with low B12, whether from dietary restriction, aging, or conditions like pernicious anemia, cannot absorb enough B12 through food or oral supplements alone
Note: Product availability and specifications subject to change
As new red blood cells form rapidly, potassium may move from the bloodstream into these cells